Xcelerate Inc (XCRT)

[RUPHERT]

Xcelerate, Inc. Announces That ESN Group, Inc. Has Been
Approved as a Vendor to Army & Air Force Exchange Service
Mauldin, SC., September 14, 2023 --Xcelerate, Inc. (OTCQB: "XCRT”) today
announced that ESN Group, Inc., a subsidiary of Xcelerate, has been designated as
an approved vendor to the Army & Air Force Exchange Service (“AAFES”). AAFES,
also known as PX and Post Exchange, provides goods and services to more than
3,000 U.S. Army and Air Force installations across 50 U.S. states and more than 30
countries as well as online. The approval is for 21 ESN products including all seven
Ceramedx® products. Ceramedx® is the first plant-based ceramide therapy system
developed in consultation with dermatologists for dry, sensitive skin and conditions
such as eczema.
“This approval is the result of a joint effort between Jay Kline, President of ESN and
John Porter of Product Sector, our recently engaged marketing partner. I am
amazed and appreciative of how much progress has been made by Jay and John
since announcing our agreement in August and look forward to their efforts to
rapidly expand market penetration of both the Ceramedx and Earth Science Beauty
product lines. This partnership ideally positions the Company to accelerate revenue
opportunities” said Mike O’Shea, Xcelerate’s CEO.
Investors and stakeholders are encouraged to stay updated on the latest
developments by visiting the company’s website at https://xcelerate.global/.
ABOUT XCELERATE INC.
In May 2020, Xcelerate commenced implementation of a new business plan that encompasses
two separate but related businesses within the medical industry, including (i) owning and
licensing the rights to various forms of medical equipment and portfolio of patents, patents
pending and technology licenses and (ii) development of virtual health technology to assist
patients in developing countries obtain medical care by extending the reach of physicians
through the use of that technology. For more information visit www.xcelerate.global or contact
us at 854-900-2020 or email [e-mail].